Literature DB >> 8537055

Expression of the APC gene after transfection into a colonic cancer cell line.

R Hargest1, R Williamson.   

Abstract

Mutations in the adenomatous polyposis coli (APC) gene cause the hereditary cancer syndrome familial adenomatous polyposis and are implicated in the early stages of sporadic colorectal carcinogenesis. APC is therefore a promising candidate for use in prophylactic gene therapy of intestinal tissues at high risk of becoming malignant. The aim of the study was to discover if functional full length APC gene can be introduced into somatic gut epithelial cells and to define the optimum conditions for such transfer. Copies of the normal APC gene were introduced into SW480 cells, a colonic epithelial cell line with an APC gene mutation, using plasmid DNA combined with liposomes. Reverse transcriptase polymerase chain reaction and restriction enzyme digestion allowed the endogenous gene to be distinguished from the transgene. It was shown that the normal APC gene is expressed at high levels for 72 hours after transfection and disappears within one week. This study shows that short-term expression of normal APC gene can be achieved after transfection with liposome-DNA complexes at sufficiently high levels to permit assessment of biological effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537055      PMCID: PMC1382946          DOI: 10.1136/gut.37.6.826

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.

Authors:  R G Crystal; N G McElvaney; M A Rosenfeld; C S Chu; A Mastrangeli; J G Hay; S L Brody; H A Jaffe; N T Eissa; C Danel
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

2.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

3.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

4.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

Authors:  F L Moolten
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

5.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

7.  Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice.

Authors:  E W Alton; P G Middleton; N J Caplen; S N Smith; D M Steel; F M Munkonge; P K Jeffery; D M Geddes; S L Hart; R Williamson
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

8.  Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.

Authors:  R M Blaese; K W Culver; L Chang; W F Anderson; C Mullen; A Nienhuis; C Carter; C Dunbar; S Leitman; M Berger
Journal:  Hum Gene Ther       Date:  1993-08       Impact factor: 5.695

9.  Chromosome 5 allele loss in human colorectal carcinomas.

Authors:  E Solomon; R Voss; V Hall; W F Bodmer; J R Jass; A J Jeffreys; F C Lucibello; I Patel; S H Rider
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

10.  Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia.

Authors:  M Grossman; S E Raper; K Kozarsky; E A Stein; J F Engelhardt; D Muller; P J Lupien; J M Wilson
Journal:  Nat Genet       Date:  1994-04       Impact factor: 38.330

View more
  4 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Cell proliferation in gastrointestinal mucosa.

Authors:  W M Wong; N A Wright
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

3.  SMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumors.

Authors:  Masaki Kiga; Ayako Nakayama; Yuki Shikata; Yukiko Sasazawa; Ryo Murakami; Toshiyuki Nakanishi; Etsu Tashiro; Masaya Imoto
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

4.  Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells.

Authors:  S Watarai; M Onuma; Y Aida; H Kakidani; H Kodama; T Yasuda
Journal:  Jpn J Cancer Res       Date:  1998-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.